Gene Therapy Might Soon Solve The Quest For How Can I Make Hair Thicker
Becker's Hospital Review: The future GLP-1 might be a gene therapy: Report
In common speech, "gene" is often used to refer to the hereditary cause of a trait, disease, or condition—as in "the gene for obesity." Speaking more precisely, a biologist might refer to an allele or a mutation that "has been implicated in" or "is associated with" obesity. NPR: Gene therapy for a rare type of deafness shows lasting results
Gene Therapy in Numbers Infographic
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients. Fierce Biotech: Eying 3 approvals in 2 years, Ocugen’s CEO wants to bring gene therapy to the masses To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri, Ph.D., said, meaning they ...
Eying 3 approvals in 2 years, Ocugen’s CEO wants to bring gene therapy to the masses Labiotech.eu: The future of cell & gene therapy: Key trends to watch Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends. Managed Healthcare Executive: Gene therapy may be a once-in-lifetime treatment. That gives some patients and providers pause and a willingness to ‘wait it out’ until a better therapy comes along | AMCP ... Pfizer announced in February 2025 that it was taking Beqvez (fidanacogene elaparvovec), its gene therapy for hemophilia B, off the market, and BioMarin is pulling Roctavian (valoctocogene roxaparvovec ...
Gene therapy may be a once-in-lifetime treatment. That gives some patients and providers pause and a willingness to ‘wait it out’ until a better therapy comes along | AMCP ... FierceBiotech: Regenxbio posts clean safety profile for DMD gene therapy as pivotal data loom Regenxbio has guided its Duchenne muscular dystrophy (DMD) gene therapy candidate through another test, reporting a clean safety profile and functional improvements as it heads toward pivotal data. Regenxbio posts clean safety profile for DMD gene therapy as pivotal data loom As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24. Managed Healthcare Executive: Gene therapy brims with promise. The reality has been less rosy for some therapies | AMCP Annual 2026 Gene therapy brims with promise. The reality has been less rosy for some therapies | AMCP Annual 2026 Yahoo: Doctors awarded science ‘Oscar’ for curing inherited blindness with gene therapy Three scientists have won the 2026 Breakthrough Prize for developing Luxturna — the world's first FDA-approved gene therapy for inherited blindness. The Philadelphia Inquirer on MSN: Philly scientists win 2026 Breakthrough Prize for developing gene therapy for blindness
